Differential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons

International Journal of Neuropsychopharmacology

Volumn 17, Issue 11, 2014, Pages 1831-1846

  Park, Sung Woo ^a   Lee, Jung Goo ^a,b   Seo, Mi Kyoung ^a   Lee, Chan Hong ^a   Cho, Hye Yeon ^a   Lee, Bong Ju ^b   Seol, Wongi ^c   Kim, Young Hoon ^a,b  

^a Inje University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Antidepressant drugs; hippocampal dendritic outgrowth; ketamine; mammalian target of rapamycin; synaptic proteins

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; INITIATION FACTOR 4E BINDING PROTEIN 1; KETAMINE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PAROXETINE; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE; SERTRALINE; TRANYLCYPROMINE; CARRIER PROTEIN; EIF4EBP1 PROTEIN, RAT; MTOR PROTEIN, RAT; ONCOPROTEIN; PHOSPHOPROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; FETUS; HIPPOCAMPUS; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CARRIER PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; NEURITES; NEURONS; ONCOGENE PROTEIN V-AKT; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84929942840     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000534     Document Type: Article

References (62)

1. Abe N, Borson SH, Gambello MJ, Wang F, Cavalli V (2010) Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves. J Biol Chem 285:28034-28043.
2. Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F (2005) Strategies for producing faster acting antidepressants. Drug Discov Today 10:578-585.
3. Artigas F (2001) Limitations to enhancing the speed of onset of antidepressants - are rapid action antidepressants possible? Hum Psychopharmacol 16:29-36.
4. Ayuso MI, Hernandez-Jimenez M, Martin ME, Salinas M, Alcazar A (2010) New hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress. J Biol Chem 285:34355-34363.
5. Bastianetto S, Danik M, Mennicken F, Williams S, Quirion R (2006) Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. BMC Neurosci 7:28.
6. Castrén E (2005) Is mood chemistry? Nat Rev Neurosci 6:241-246.
7. Chandran A, Iyo AH, Jernigan CS, Legutko B, Austin MC, Karolewicz B (2012) Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Prog Neuropsychopharmacol Biol Psychiatry 40:240-245.
8. Chen F, Madsen TM, Wegener G, Nyengaard JR (2008) Changes in rat hippocampal CA1 synapses following imipramine treatment. Hippocampus 18:631-639.
9. Chen F, Madsen TM, Wegener G, Nyengaard JR (2010) Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus 20:1376-1384.
10. Dikmen M, Canturk Z, Özturk Y (2011) Escitalopram oxalate, a selective serotonin reuptake inhibitor, exhibits cytotoxic and apoptotic effects in glioma C6 cells. Acta Neuropsychiatrica 23:173-178.
11. Duman RS, Voleti B (2012) Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 35:47-56.
12. Duman RS, Li N, Liu RJ, Duric V, Aghajanian G (2012) Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62:35-41.
13. Fang ZH, Lee CH, Seo MK, Cho H, Lee JG, Lee BJ, Park SW, Kim YH (2013) Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci Res 76:187-194.
14. Fava M (2003) Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53:649-659.
15. Ehrlich I, Klein M, Rumpel S, Malinow R (2007) PSD-95 is required for activity-driven synapse stabilization. Proc Natl Acad Sci USA 104:4176-4181.
16. Gould TD, Einat H, Bhat R, Manji HK (2004) AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7:387-390.
17. Hajszan T, MacLusky NJ, Leranth C (2005) Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci 21:1299-1303.
18. Han K, Kim E (2008) Synaptic adhesion molecules and PSD-95. Prog Neurobiol 84:263-283.
19. Hashimoto K (2011) Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine. Expert Rev Neurother 11:33-36.
20. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926-1945.
21. Hirschfeld RM (2012) Depression epidemiology and its treatment evolution. J Clin Psychiatry 73:e29.
22. Hoeffer CA, Klann E (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33:67-75.
23. Horikawa H, Kato TA, Mizoguchi Y, Monji A, Seki Y, Ohkuri T, Gotoh L, Yonaha M, Ueda T, Hashioka S, Kanba S (2010) Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry 34:1306-1316.
24. Jan YN, Jan LY (2003) The control of dendrite development. Neuron 40:229-242.
25. Jernigan CS, Goswami DB, Austin MC, Iyo AH, Chandran A, Stockmeier CA, Karolewicz B (2011) The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35:1774-1779.
26. Kaech S, Banker G (2006) Culturing hippocampal neurons. Nat Protoc 1:2406-2415.
27. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus. Biol Psychiatry 55:781-784.
28. Kessler RC, Bromet EJ (2013) The epidemiology of depression across cultures. Annu Rev Public Health 34:119-138.
29. Klann E, Antion MD, Banko JL, Hou L (2004) Synaptic plasticity and translation initiation. Learn Mem 11:365-372.
30. Klimaschewski L, Nindl W, Pimpl M, Waltinger P, Pfaller K (2002) Biolistictransfection and morphological analysis of cultured sympathetic neurons. J Neurosci Methods 15:63-71.
31. Kumar V, Zhang MX, Swank MW, Kunz J, Wu GY (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25:11288-11299.
32. Lalli G, Hall A (2005) Ral GTPases regulate neurite branching through GAP-43 and the exocyst complex. J Cell Biol 171:857-869.
33. Lee FS, Rajagopal R, Chao MV (2002) Distinctive features of Trk neurotrophin receptor transactivation by G protein-coupled receptors. Cytokine Growth Factor Rev 13:11-17.
34. Li X, Jope RS (2010) Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35:2143-2154.
35. Li Z, Tan F, Thiele CJ (2007) Inactivation of glycogen synthase kinase-3β contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Mol Cancer Ther 6:3113-3121.
36. Li L, Xu B, Zhu Y, Chen L, Sokabe M, Chen L (2010a) DHEA prevents Aβ25-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling. Neuropharmacology 59:323-333.
37. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010b) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959-964.
38. Lin CJ, Robert F, Sukarieh R, Michnick S, Pelletier J (2010) The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling. Cancer Res 70:3199-3208.
39. Lom B, Cohen-Cory S (1999) Brain-derived neurotrophic factor differentially regulates retinal ganglion cell dendritic and axonal arborization in vivo. J Neurosci. 19:9928-9938.
40. McAllister AK, Katz LC, Lo DC (1999) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22:295-318.
41. Mendoza MC, Er EE, Blenis J (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 36:320-328.
42. Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, Murase T, Yoshikawa H (2011) Akt/mammalian target of rapamycin signaling pathway regulates neurite outgrowth in cerebellar granule neurons stimulated by methylcobalamin. Neurosci Lett 495:201-204.
43. Parsa AT, Holland EC (2004) Cooperative translational control of gene expression by Ras and Akt in cancer. Trends Mol Med 10:607-613.
44. Peng CH, Chiou SH, Chen SJ, Chou YC, Ku HH, Cheng CK, Yen CJ, Tsai TH, Chang YL, Kao CL (2008) Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol 18:128-140.
45. Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88-109.
46. Pizzorusso T, Ratto GM, Putignano E, Maffei L (2000) Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J Neurosci 20:2809-2816.
47. Post A, Crochemore C, Uhr M, Holsboer F, Behl C (2000) Differential induction of NF-κB activity and neural cell death by antidepressants in vitro. Eur J Neurosci 12:4331-4337.
48. Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, Polakiewicz RD, Sonenberg N, Hershey JW (2004) Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23:1761-1769.
49. Rodgers EE, Theibert AB (2002) Functions of PI 3-kinase in development of the nervous system. Int J Dev Neurosci 20:187-197.
50. Rosa AO, Kaster MP, Binfaré RW, Morales S, Martín-Aparicio E, Navarro-Rico ML, Martinez A, Medina M, García AG, López MG, Rodrigues AL (2008) Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry 32:1549-1556.
51. Russo E, Citraro R, Donato G, Camastra C, Iuliano R, Cuzzocrea S, Constanti A, De Sarro G (2013) mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology 69:25-36.
52. Seo MK, Lee CH, Cho HY, Lee JG, Lee BJ, Kim JE, Seol W, Kim YH, Park SW (2014) Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures. Neuropharmacology 79:222-233.
53. Takei N, Kawamura M, Ishizuka Y, Kakiya N, Inamura N, Namba H, Nawa H (2009) Brain-derived neurotrophic factor enhances the basal rate of protein synthesis by increasing active eukaryotic elongation factor 2 levels and promoting translation elongation in cortical neurons. J Biol Chem 284:26340-26348.
54. Tang SJ, Schuman EM (2002) Protein synthesis in the dendrite. Philos Trans R Soc Lond B Biol Sci 357:521-529.
55. Valtorta F, Pennuto M, Bonanomi D, Benfenati F (2004) Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? Bioessays 26:445-453.
56. Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG (2001) Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 20:4370-4379.
57. Wang X, Li W, Parra JL, Beugnet A, Proud CG (2003) The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation. Mol Cell Biol 23:1546-1557.
58. Wong M (2013) Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J 36:40-50.
59. Workman ER, Niere F, Raab-Graham KF (2013) mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling. Neuropharmacology 73:192-203.
60. Wu Y, Blum D, Nissou MF, Benabid AL, Verna JM (1996) Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition. Neurosci Lett 221:69-71.
61. Yang C, Hu YM, Zhou ZQ, Zhang GF, Yang JJ (2013) Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Ups J Med Sci 118:3-8.
62. Zarate CA Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864.